IDEAYA Biosciences (IDYA)

IDEAYA Biosciences (IDYA) Financial Statements


IDEAYA Biosciences Financial Overview

IDEAYA Biosciences's market cap is currently ―. The company's EPS TTM is $-2.001; its P/E ratio is -18.48; IDEAYA Biosciences is scheduled to report earnings on August 12, 2024, and the estimated EPS forecast is $-0.55. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue-$ 3.92M$ 3.54M$ 7.88M$ 4.02M
Gross Profit-$ 3.92M$ 3.54M$ 7.88M$ 4.02M
EBIT$ -51.02M$ -41.92M$ -27.93M$ -23.64M$ -26.44M
EBITDA$ -49.94M$ -40.89M$ -29.48M$ -24.24M$ -27.54M
Net Income Common Stockholders$ -41.06M$ -33.95M$ -27.93M$ -23.64M$ -24.20M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 698.77M$ 525.11M$ 493.72M$ 339.47M$ 364.83M
Total Assets$ 961.53M$ 649.32M$ 527.56M$ 364.75M$ 387.97M
Total Debt$ 2.41M$ 2.87M$ 2.57M$ 3.03M$ 3.48M
Net Debt$ -696.37M$ -522.24M$ -491.14M$ -336.44M$ -361.35M
Total Liabilities$ 26.22M$ 28.23M$ 25.95M$ 30.94M$ 38.51M
Stockholders Equity$ 935.35M$ 621.09M$ 501.58M$ 333.81M$ 349.45M
Cash Flow-
Free Cash Flow$ -45.14M$ -24.59M$ -34.34M$ -27.89M$ -23.37M
Operating Cash Flow$ -43.81M$ -23.75M$ -33.46M$ -27.84M$ -23.37M
Investing Cash Flow$ -353.97M$ -111.94M$ -121.38M$ 23.52M$ -10.28M
Financing Cash Flow$ 349.11M$ 140.89M$ 191.06M$ 2.93M$ 324.00K
Currency in USD

IDEAYA Biosciences Earnings and Revenue History

IDEAYA Biosciences Debt to Assets

IDEAYA Biosciences Cash Flow

IDEAYA Biosciences Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis